unilife's products shows a weak business case , page-26

Flyingtiger....the facts are we completed the IA for Unifill in mid 2011. 30 months later how many Unifill are on the shelf with customers drugs in them?

I like your enthusiasm...but there are questions why 30 months after "initial sales...stability trials" that if our Unifill actually has market demand then why are we still looking at back half of 2014 before we "may" have syringes on the shelf?

Especially if this device can practially crawl back lost market share due to its differentiation. That sounds like the sort of thing that if the business model stacked up I would be expediting through my business processes

UNIFILL IS AN AMAZING LITTLE THNG!!!! There has to be valid reasons why they are not on the shelf today.

Its completely reasonable to expect an esiting drug being migrated over that from start of stability trials to going on sale would be an 18-24 month window. The fact that we missed that window I started asking just what is the demand?

I have no doubt the market exists....I think I just over estimated it. I think UNS will be successful, but my measure of successful I suspect is well under what some people expect from the business